1 active not recruiting, 1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Sashwati Roy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Active not recruiting | Sashwati Roy | 100 | 2019-01-08 | 2025-09-26 |
| Leukocyte Dysfunction in Diabetic Patients. Diabetes Mellitus, Type 2 | Terminated | Sashwati Roy | 42 | 2010-03-01 | 2021-11-22 |
Bronchiolitis Obliterans Syndrome (1) · Burns (1) · Diabetes Mellitus, Type 2 (1) · Diabetic Foot (1) · Pressure Ulcer (1) · Wounds and Injuries (1)
Petroleum (1)
United States (2)
PMID 11194213, PMID 34398099, PMID 4826528, PMID 8390941, PMID 971792